1. Kirloskar Launches Non-Invasive MRgFUS in India
(Communities/Ultrasound)

... 2000 in India by Kirloskar Technologies, a leading provider of high technology life saving devices, the treatment of Uterine Fibroids amongst Indian women receives a huge boost.  The Non Invasive ...

2. Jaslok Hospital Brings Ultrasound Fibroid Cure
(Communities/Ultrasound)

An ultrasound machine, a first in the country according to doctors from the Jaslok Hospital, will treat fibroids without any cuts or stitches. It will minimise the risk of losing the uterus. Moreover, ...

3. InSightec’s ExAblate MRgFUS for Uterine Fibroids
(Company News/InSightec)

... fibroids. “We are  very pleased that the Japanese Ministry of Health has approved the ExAblate system and that women in Japan will now have access to a noninvasive treatment option for uterine fibroids,” ...

4. Philips Showcases Interventional Radiology; RSNA 2009
(Company News/Philips Healthcare)

... display monitors and can be configured on new or previously installed Brilliance iCT scanners. Investigating new interventional devices Sonalleve MR- Guided HIFU Fibroid Therapy System (Investigational ...

5. InSightec Announces Three Studies Supporting Use of ExAblate & MRgFUS
(Company News/InSightec)

... and durable treatment for uterine fibroids. One study showed that non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system offers women a significantly less ...

6. CeloNova BioSciences' Embozene Microspheres Receives Approval
(Company News/CeloNova BioSciences)

... are now approved for the treatment of liver cancer, uterine fibroids, tumors of the head, neck, torso, and skeletal system; for bleeding and trauma, including nosebleeds; and for reducing the amount of ...

7. PET Scans Differentiates High- and Low-Risk Uterine Tumors
(Radiology News/Radiology Articles)

... among Dr. Okazawa's group. They are currently working on whether this method could be useful in telling apart uterine fibroids, a painful but benign condition, from the rare malignant version, leiomyosarcoma. ...

8. University of Virginia Researchers Ready to Help Revolutionize Medical Care Worldwide
(Communities/MRI)

... co-director of the new center, will provide focused ultrasound treatments to patients with uterine fibroids. "This is the first focused ultrasound treatment approved by the FDA, and it will be an important ...

9. A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients with Functional Brain Disorders
(Company News/InSightec)

... for symptomatic uterine fibroids. 5,000 women have been treated worldwide to date. ExAblate 2000 received the European CE Mark certification for pain palliation of bone metastases in June 2007. About ...

10. New MR Sequence Helps Radiologists More Accurately Evaluate Abnormalities of the Uterus and Ovaries
(Radiology Conferences/ARRS 2009)

... echo was 4.4 versus 3.0; for depiction of the ovaries, 3.5 versus 3.1; and for detection of fibroids, 3.9 versus 3.6,” he said. “Women are referred for MRI of the pelvis for a number of reasons. It is ...

11. FDA Approves Label Change For Non-Invasive Fibroid Treatment
(Company News/InSightec)

InSightec Ltd. announced that the U.S. FDA approved a label change for the company’s ExAblate® 2000 MRgFUS system for the treatment of women with non-hysteroscopically resectable uterine fibroids.  ...

12. Sonohysterography can be an Alternative Diagnostic Tool for Adenomyosis
(Communities/Abdominal Pelvic)

... said Dr. Verma. “Patients often present with symptoms of abnormal bleeding, pelvic pain and infertility which may be due to a uterine fibroid, a polyp, tumor or adenomyosis. MR imaging is expensive and ...

13. Project To Raise Awareness of Ultrasound Uterine Fibroid Procedure
(Communities/Ultrasound)

... outpatient uterine fibroid treatment using high energy ultrasound will begin in the Chicago area in March, led by two prominent and well respected African American gynecologists, Dr. Leonard Lawson and ...

14. Noninvasive ExAblate® Treatment for Uterine Fibroids is Cost-Effective, New Study Says
(Communities/Ultrasound)

... 25, Issue 1) of The International Journal of Technology Assessment in Health Care. “This study shows that treating uterine fibroids with MRgFUS is a cost-effective option for payers” said David Lee Ph.D., ...

15. Capstone RSNA 2008 Review
(Radiology Conferences/RSNA 2008)

... than previously reported. Not to overshadow RSNA itself, where MedicExchange covered prominent studies such as a *doubling in NPV results* from use of MRgFUS for uterine fibroids. An important market launch ...

16. MRgFUS Shrinks Uterine Fibroids by 33%, Study Shows
(Radiology Conferences/RSNA 2008)

Magnetic resonance-guided focused ultrasound (MRgFUS) treatment of uterine fibroids in an outpatient practice can yield significantly greater non-perfused volume (NPV) and shrinkage than other methods, ...

17. Doubled Results from Prior 15% to Current Average of 33% NPV Use of MRgFUS for Uterine Fibroids
(Radiology Conferences/RSNA 2008)

Magnetic resonance-guided focused ultrasound (MRgFUS) treatment of uterine fibroids in an outpatient practice can yield net perfused volume (NPV) and shrinkage greater than previous results, according ...

18. Major surgery no longer needed for the removal of uterine fibroids
(Radiology Conferences/ARRS 2008)

The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, non-invasive and effective, according to a recent study conducted by researchers in New York, NY. The treatment ...

19. Enhanced MR-guided focused ultrasound guidelines demonstrate improved efficacy and durability
(Communities/Ultrasound)

... need for alternative, invasive treatments. Data released on Tuesday show that MR-guided focused ultrasound (MRgFUS) is a more effective option for a broader population of uterine fibroid sufferers. In ...

20. Medicare proposed HOPPS changes for 2008
(Radiology News/Radiology Articles)

... payment rate for APC 0282 is $105.48. Ultrasound ablation of uterine fibroids with magnetic resonance guidance (MRgFUS) (APCs 0195 and 0202) CMS is proposing to accept the APC Panel's recommendation ...